Thromboembolic risks and complications in nephrotic children

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 3, 1997, Pages 271-280

  Schlegel, Nicole ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Albuminuria hyper coagulability; Children; Hypofibrinolysis; Nephrotic syndrome; Thromboembolism

Indexed keywords

BLOOD CLOTTING; CHILD; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MEDICAL RESEARCH; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

EID: 0030879117     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996100     Document Type: Review

References (88)

1. Ritz E: Pathogenesis of "idiopathic" nephrotic syndrome. N Engl J Med 330:61-62, 1994.
2. Dantal J, E Bigot, W Bogers: Effect of plasma protein absorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14, 1994.
3. Segatchian MJ, MM Samama: Hypercoagulable states: An overview. In: Segatchian MJ, MM Samama, SP Hecker (Eds):Hypercoagulable States. Fundamental Aspects, Acquired Disorders, and Congenital Thrombophilia. CRC Press, Boca Raton, 1996, pp 2-17.
4. Andrew M: Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients. Thromb Haemostas 74:415-425, 1995.
5. Schlegel N: Hypercoagulability in children and neonates. In: Segatchian MJ, MM Samama, SP Hecker (Eds): Hypercoagulable States. Fundamental Aspects, Acquired Disorders, and Congenital Thrombophilia. CRC Press, Boca Raton, 1996, pp 259-266.
6. Bounameaux H: Biological markers of acute venous thrombosis and pulmonary embolism. In: Segatchian MJ, MM Samama, SP Hecker (Eds): Hypercoagulable States. Fundamental Aspects, Acquired Disorders, and Congenital Thrombophilia. CRC Press, Boca Raton, 1996, pp 129-137.
7. Gaffney PJ: Fibrinolysis and the hypercoagulable state. In: Segatchian MJ, MM Samama, SP Hecker (Eds): Hypercoagulable States. Fundamental Aspects, Acquired Disorders, and Congenital Thrombophilia. CRC Press, Boca Raton, 1996, pp 117-127.
8. Trzeciak MC, JC Bordet, M Dechavanne: Diagnosis of activation states of circulating platelets. In: Segatchian MJ, MM Samama, SP Hecker (Eds): Hypercoagulable States. Fundamental Aspects, Acquired Disorders, and Congenital Thrombophilia. CRC Press, Boca Raton, 1996, pp 87-99.
9. Kanter A, D Kleinknecht, M Broyer, F Josso: Coagulation studies in 45 cases of nephrolic syndrome without uremia. Thromb Diathes Haemorrh 24:562-571, 1970.
10. Kendall AG, RC Lohmann, JB Dossetor: Nephrotic syndrome: A hypercoagulable state. Arch Intern Med 127:1021-1027, 1971.
11. Jandrot M: Comportement des protéines de la coagulation au cours du syndrome néphrotique. Thèse de Médecine, Faculté de Médecine Necker-Enfants Malades, Université René Descartes, Paris 1977.
12. Loirat C, G Pillion, N Schlegel, R Douenias, H Mathieu: Etude des protéines de la coagulation et de la fibrinolyse au cours des syndromes néphrotiques de l'enfant. Arch Fr Pediatr 36(suppl 1): 56-63, 1979.
13. Vaziri ND, HE Branson, R Ness: Changes of coagulation factors IX, VIII, VII, X and V in nephrotic syndrome. Am J Med Sci 280:167-170, 1980.
14. Rabelink T, JJ Zwaginga, HA Koomans, JJ Sixma: Thrombosis and hemostasis in renal disease. Kidney Int 46:287-296, 1994.
15. Zwaginga JJ, HA Koomans, JJ Sixma, AJ Rabelink: Thrombus formation and platelet vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest 931:204-211, 1994.
16. Cameron JS, CS Ogg, VJ Wass: Complications of the nephrotic syndrome. In: Cameron JS, RJ Glassock (Eds): The Nephrotic Syndrome. Marcel Dekker, New York, 1988, pp 849-920.
17. Cameron JS: Clinical consequences of the nephrotic syndrome. In: Cameron JS, AM Davison, JP Grunfeld, D Kerr, E Ritz (Eds): Oxford Textbook of Clinical Nephrology. Oxford Medical Publication, 1992, pp 276-297.
18. Vaziri ND: Nephrotic syndrome and coagulation and fibrinolytic abnormalities. Am J Nephrol 3:1-6, 1983.
19. Cameron JS: Coagulation and thromboembolic complications in the nephrotic syndrome. Adv Nephrol 13:75-114, 1984.
20. Cosio FG, C Harker, MA Batard, JT Brandt, JH Griffin: Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med 106:218-222, 1985.
21. Kauffmann RH, TJ Veltkamp, N Van Tilburg, LA Van Es: Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 65:607-613, 1978.
22. Boneu B, F Bouissou, M Abbal, P Sié, C Caranobe, P Barthe: Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Thromb Haemostas 46:623-625, 1981.
23. Vaziri ND, P Paule, J Toohey, E Hung, S Alikhani, R Drawish, M Pahl: Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 144:1802-1803, 1984.
24. Thompson C, CD Forbes, CR Prentice, AC Kennedy: Changes in blood coagulation and fibrinolysis in the nephrotic syndrome. Q J Med 43:399-407, 1974.
25. Rydzewski A, M Mysliwiec, J Soszka: Concentration of three thrombin inhibitors in the nephrotic syndrome in adults. Nephron 42:200-203, 1986.
26. Andrew M, P Vegh, M Johnston, J Bowker, F Ofosu, L Mitchell: Maturation of the hemostatic system during childhood. Blood 80:1998-2005, 1992.
27. Mehls O, K Andrassy, J Koderisch, U Herzog, E Ritz: Haemostasis and thromboembolism in children with nephrotic syndrome: Differences from adults. J Pediatr 6:862-867, 1987.
28. Sala N, A Oliver, X Estivill, R Moreno, J Félez, ML Rutllant: Plasmatic and urinary protein C levels in nephrotic syndrome. Thromb Haemostas 54:900 (Lett), 1985.
29. Pabinger-Fasching I, K Lechner, H Niessner, P Schmidt, E Balzar, C Mannhalter: High levels of plasma protein C in nephrotic syndrome. Thromb Haemostas 53:5-7, 1985.
30. Mannucci PM, C Valsecchi, B Bottasso, A D'Angelo, S Casati, C Ponticelli: High plasma levels of protein C activity and antigen in the nephrotic syndrome. Thromb Haemostas 55:31-33, 1986.
31. Vigano-D'Angelo S, A D'Angelo, CE Kaufman, C Sholer, CT Esmon, PC Comp: Protein S deficiency occurs in the nephrotic syndrome. Ann Intern Med 107:42-47, 1987.
32. Vaziri ND, S Alikhani, B Patel, Q Nguyen, CH Barton, EV Gonzales: Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. Nephron 49: 20-23, 1988.
33. Gouault-Heilmann M, T Gadelha-Parente, M Levent, L Intrator, G Rostoker, G Lagrue: Total and free protein S in nephrotic syndrome. Thromb Res 49:37-42, 1988.
34. Ueda N, S Kawaguchi, Y Niinomi, T Nonoda, J Matsumoto, M Ohnishi, T Yasaki: Effect of corticosteroids on coagulation factors in children with nephrotic syndrome. Pediatr Nephrol 1:286-289, 1987.
35. De Mattia D, R Penza, P Giordano, G Di Bitonto, M Altomare, GC Delvecchio, F Schettini: Thromboembolic risk in children with nephrotic syndrome. Haemostasis 21:300-304, 1991.
36. Andre E, P Voisin, JL Andre, ME Briquel, JF Stoltz N Martinet, P Alexandre: Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy. Nephron 68:184-191, 1994.
37. Al-Mugeiren MM, AMA Gader, SA Al-Rasheed, HM Bahakim, AK Al-Momen, A Al-Salloum: Coagulopathy in childhood nephrotic syndrome. A reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis 26:304-310, 1996.
38. Fischer AM, J Tapon-Bretaudiere, A Bros, F Josso: Respective roles of antithrombin III and alpha-2-macroglobulin in thrombin inactivation. Thromb Haemostas 45:51-54, 1981.
39. Schmidt B, L Mitchell, F Ofosu, M Andrew: Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemostas 62:1074-1077, 1992.
40. Shah JK, LG Mitchell, B Paes, F Ofosu, B Schmidt, M Andrew: Thrombin inhibition is impaired in plasma of sick neonates. Pediatr Res 31:391-395, 1992.
41. Andrew M, LG Mitchell, P Vegh, F Ofosu: Thrombin regulation in children differs from adults in the absence and presence of heparin. Pediatr Haemostas 72:836-842, 1994.
42. Bertina RM, BPC Koeleman, T Koster, R Rosendaal, RJ Dirven, H de Ronde, PA Van der Velden, PH Reitsma: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67, 1994.
43. Dahlbäck B, M Carlsson, PJ Svensson: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90: 1004-1008, 1993.
44. Dahlbäck B, B Hildebrand: Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a properly of factor V. Proc Natl Acad Sci USA 91:1396-1399, 1994.
45. Zöller B, PH Svensson, X He, B Dahlbäck: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 94:2521-2524, 1994.
46. Maisonneuve L, C Loirat, S Binard, MF Hurtaud-Roux, V Baudouin, P Brun, N Schlegel: Factor V Leiden in 51 nephrotic children. Blood 86(suppl 1):920a (Abst), 1995.
47. Poort SR, FR Rosendaal, PH Reitsma, RM Bertina: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
48. Angles-Cano E, L Hervio, D Rouy, C Fournier, JM Chapman, M Laplaud, ML Koshinsky: Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator. Chem Phys Lipids 67/68:369-380, 1993.
49. Querfeld U, M Lang, JB Friedrich, B Korl, W Fiehn, K Schärer: Lipoprotein (a) serum levels and apolipoprotein (a) phenotypes in children with chronic renal disease. Pediatr Res 34:772-776, 1993.
50. Hervio L, MJ Chapman, J Thillet, S Loyau, E Angles-Cano: Does apolipoprotein (a) heterogeneity influence lipoprotein (a) effects on fibrinolysis? Blood 82:392-397, 1993.
51. Lau SO, JY Tkachuck, DK Hasegawa, JR Edson: Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr 96:390, 1980.
52. Loirat C, T Soulat, S Loyau, L Maisonneuve, N Schlegel, MF Hurtaud-Roux, E Angles-Cano: Abnormalities of coagulation and fibrinolysis in the nephrotic syndrome. Pediatr Nephrol 10:C105 (Abst), 1996.
53. Du XH, P Glas-Greenwalt, KS Kant, CM Allen, S Hayes, VE Pollak: Nephrotic syndrome with renal vein thrombosis: Pathogenic importance of a plasmin inhibitor (alpha-2-antiplasmin). Clin Nephrol 24:186-191, 1985.
54. Gandrille S, M Aiach: Albumin concentration influences fibrinolytic activity in plasma and purified systems. Fibrinolysis 4:225-232, 1990.
55. Loirat C, MF Hurtaud-Roux, N Schlegel, P Brun: Thromboembolic complications in nephrotic syndrome. Pediatr Nephrol 6: C67, 1992.
56. Gader AMA, JL Anderton, JD Cash: The fibrinolytic response to venous occlusion in hypoproteinaemic patients. Thromb Res 3: 219-221, 1973.
57. Gandrille S, MH Jouvin, P Toulon, P Remy, JN Fiessinger, M Roncato, N Moatti, M Aiach: A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndrome. Thromb Haemostas 59: 445-450, 1988.
58. Siegbahn A, L Ruusuwaara: Age dependence of blood fibrinolytic components and the effects of low dose oral contraceptive on coagulation and fibrinolysis of teenagers. Thromb Haemostas 60: 361-364, 1988.
59. Wheeler D, DB Bernard: Lipid abnormalities in the nephrotic syndrome: Causes, consequences and treatment. Am J Kidney Dis 23:331-346, 1994.
60. Utermann G, HJ Menzel, HG Kraft, HC Dubs, HG Kemmler, C Seitz: Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) lipoprotein concentrations in plasma. J Clin Invest 80:558-565, 1987.
61. Kanfer A: Coagulation factors in nephrotic syndrome. Am J Nephrol 10 (suppl 1):63-68, 1990.
62. Yoshida N, N Aoki: Release of arachidonic acid from human platelets, a key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 52:969-977, 1978.
63. Bennett A, JS Cameron: Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration. Clin Nephrol 27:182-188, 1987.
64. Walter E, D Deppermann, K Andrassy, J Kodreisch: Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res 23:473-479, 1981.
65. Schieppati A, P Dodesini, A Benigni, M Massazza, G Mecca, G Remuzzi, M Livio, G de Gaetano, EC Rossi: The metabolism of arachidonic acid by platelets in nephrotic syndrome. Kidney Int 25:671-676, 1984.
66. Rostoker G, M Gouault-Heilmann, P Lang, G Lagrue: Anomalies of coagulation and thromboembolic complications of nephrotic syndrome. Pathol Biol 35:195-199, 1987.
67. Elidrissy ATH, MB Abdurrahman, HM Bahakim, MD Jones, AMA Gader: Haemostatic measurements in childhood nephrotic syndrome. Eur J Pediatr 150:374-378, 1991.
68. 2 release and cAMP concentration of the platelets in nephrotic syndrome. Prostaglandins Leukotrienes Essential Fatty Acids 51:69-73, 1994.
69. Remuzzi G, G Mecca, D Marchesi, M Livio, G De Gaetano, MB Donati, MJ Siver: Platelet hyperaggregability and the nephrotic syndrome. Thromb Res 16:345-354, 1979.
70. Stuart MJ, RE Spitzer, DA Nelson, RH Sills: Nephrotic syndrome: Increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission. Pediatr Res 14:1078-1081, 1480.
71. Machleidt C, T Mettang, E Stärz, J Weber, T Risler, U Kuhlmann: Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome. Kidney Int 36:1119-1124, 1989.
72. Jackson CA, M Greaves, AD Patterson, CB Brown, FE Preston: Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol 52:69-77, 1982.
73. Al-Mugeiren MM, AMA Gader, SA Al-Rasheed, HM Bahakim, AK Al-Momen, A Al-Sulloum: Platelet aggregometry - Dose-related responses to arachidonic acid in childhood nephrotic syndrome. Platelets 6:71-74, 1995.
74. Böhler T, O Linderkamp, A Leo, AM Wingen, K Schärer: Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome. Clin Nephrol 38:119-124, 1992.
75. Tomura S, Y Oono, R Kuriyama, J Takeuchi: Plasma concentrations of fibrinopeptide A and fibrinopeptide Bβ15-42 in glomerulonephritis and the nephrotic syndrome. Arch Intern Med 145: 1033-1035, 1985.
76. Sagripanti A, A Cupisti, M Ferdeghini, E Pinori, G Barsotti: Molecular markers of hemostasis activation in nephrotic syndrome. Nephron 51:25-28, 1989.
77. Llach F: Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28: 429-439, 1985.
78. Egli F, P Elminger, G Stalder: Thromboembolism in nephrotic syndrome. Pediatr Res 8:903 (Abst), 1973.
79. Egli F: Thromboembolism beim nephrotischen Syndrom im Kindesalter. Thesis. University of Basel, 1974.
80. Beaufils F, N Schlegel, C Loirat, R Marotte, G Pillion, H Mathieu: Urokinase treatment of pulmonary artery thrombosis complicating the pediatric nephrotic syndrome. Crit Care Med 13:132-134, 1985.
81. Bernard DB: Extrarenal complications of the nephrotic syndrome. Kidney Int 33:1184-1202, 1988.
82. Lye WC, Tan CC: Multiple arterial thrombosis in nephrotic syndrome. Nephrol Dial Transplant 6:55-56, 1991.
83. Dodd K, RJ Johansmann, S Rapaport: Thrombosis of the vena cava and hepatic veins (Chiari's syndrome) in a patient with nephrosis. Am J Dis Child 76:316, 1948.
84. Lieberman E, E Heuser, GS Gilchrist: Thrombosis, nephrosis and corticosteroid therapy. J Pediatr 73:320-328, 1968.
85. Hoyer PF, S Gonda, M Barthels, P Krohn, J Brodehl: Thromboembolic complications in children with nephrotic syndrome. Acta Paediatr Scand 75:804-810, 1986.
86. Guillot M, AM Fischer, D Goldszmidt, JL Bacri, M Gagnadoux, M Usberti, F Josso, M Broyer: Syndrome néphrotique, déficit en antithrombine III et thromboses à répétition. Arch Fr Pediatr 36: 930-933, 1979.
87. Jones CL, D Hebert: Pulmonary thromboembolism in the nephrotic syndrome. Pediatr Nephrol 5:56-58, 1991.
88. Michelson AD, E Bovill, M Andrew: Antithrombotic therapy in children. Chest 108:506S-522S, 1995.